Combination antiretroviral use and preterm birth.

The Journal of infectious diseases

Volumn 207, Issue 4, 2013, Pages 612-621

  Watts, D Heather ^a   Williams, Paige L ^b   Kacanek, Deborah ^b   Griner, Raymond ^b   Rich, Kenneth ^b   Hazra, Rohan ^b   Mofenson, Lynne M ^b   Mendez, Hermann A ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG COMBINATION; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW BIRTH WEIGHT; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; RISK FACTOR;

ADULT; ANTI-HIV AGENTS; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GESTATIONAL AGE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; REVERSE TRANSCRIPTASE INHIBITORS; RISK FACTORS; YOUNG ADULT;

EID: 84877113825     PISSN: None     EISSN: 15376613     Source Type: None    
DOI: 10.1093/infdis/jis728     Document Type: Article

References (0)